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Objectives: To compare genotypic methods for epidemiologic typing of Legionella pneumophila serogroup (sg) 1, in 
order to determine the best available method within Europe for implementation and standardization by members of the 
European Working Group on Legionella Infections. 
Methods: Coded isolates (1 14) of L. pneumophila sg 1 comprising one epidemiologically 'unrelated' (79) and one 
'related' panel of isolates (35) were sent to 12 laboratories in 11 European countries. Analysis was undertaken in each 
laboratory using one or more of the following methods: ribotyping, restriction fragment length polymorphism analysis, 
restriction endonuclease analysis, pulsed-field gel electrophoresis (PFGE), PCR using arbitraryhepeat sequence primers 
(AP-, AP/rep-PCR), and amplified fragment length polymorphism (AFLP) analysis. Results were analyzed visually or using 
gel analysis software. Each method was assessed for its: index of discrimination (D), epidemiologic concordance (0, 
speed of application and ease of use. In addition, phenotypic analysis was performed in two laboratories using 
monoclonal antibodies (mAbs). 
Results: The Dof each of the genotypic methods ranged from 0.840 for ribotyping to 0.990 for PFGE using Sfil:€ranged 
from 0.06 for AP- and AP/rep-PCR to 1.00 for ribotyping using Psd/€coRI and AFLP: in general, E was inversely related 
to D. Although offering only limited discrimination (0=0.838), mAb typing was both rapid and highly epidemiologically 
concordant (E= 1 .OO). 
Conclusions: Two methods, PFGE using Sfil and AFLP, were selected for further study. AFLP is rapid and highly 
epidemiologically concordant (€= 1 .OO), but is not highly discriminatory. This method will be developed as a rapid 
screening tool. PFGE using Sfrl is highly discriminatory but, in the present study, yielded low values of E (0.124.71). 
Attempts will be made to rigorously standardize this method for use as the reference method. Primary screening of 
isolates by mAb subgrouping is recommended. 
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INTRODUCTION 
Legionella infection (legionellosis) can vary from a mild 
respiratory illness to an acute life-threatening pneu- 
monia. Mortality rates of 4% to >30% have been 
reported [l-71, the highest rates being seen in patients 
with serious underlying disease, or where appropriate 
therapy has been delayed [1,2,4,5,8,9]. 
The increase in leisure travel, particularly within 
the European Union (EU) and its neighboring 
countries, together with a vigilant surveillance scheme 
[lo], has led to a heightened recognition of travel- 
associated cases of legionellosis. In 1997, 1360 cases of 
legionnaires’ disease from 24 European countries were 
reported by members of the European Working Group 
on Legionella Infections (EWGLI) to the coordinating 
center, the Public Health Laboratory Service (PHLS) 
Communicable Disease Surveillance Centre, London 
[ l l ] .  O f  those for which information was provided, 
32.9% (2971903) were reported to be travel-associated 
(CA Joseph, personal communication). 
Legionellosis is acquired by inhalation or aspiration 
of legionellae from a contaminated environmental 
source. Thus, when a case oflegionellosis is recognized, 
others may become infected from the same environ- 
mental source if action is not taken to reduce this risk. 
The source of the outbreak may be established by 
characterization of the environmental and clinical 
strains (Figure 1). 
The vast majority of cases of legionellosis are 
caused by L q i o d a  pneumophila, and most of these are 
serogroup (sg) 1 strains. These strains are also frequently 
encountered in the environment, so isolates of this 
serogroup must be further differentiated if any con- 
vincing epidemiologic link is to be established. 
Many methods have been described for the geno- 
typic and phenotypic typing of L. pneiirnophila sg 1 
[ 12-32]. However, with few exceptions, these methods 
have been used in a single laboratory, for the simul- 
taneous examination of a few isolates. In such 
circumstances it is not necessary to allocate isolates to 
designated ‘types’ to determine if they are distin- 
guishable, but rather simply to compare isolate ‘finger- 
prints’ directly at the time of analysis. Furthermore, in 
most cases detailed analyses with alternative typing 
methods have not been performed. 
Increasingly, in the context of travel-associated 
legionellosis, the situation arises where a patient isolate 
is obtained in one laboratory (e.g. when an infected 
person returns to his home country), and the associated 
environmental isolate(s) in another laboratory, follow- 
ing an investigation in the country where the infection 
was acquired. When detailed epidemiologic typing is 
required in such situations, the inability to directly 
compare results from one laboratory with those from 
another severely slows investigations and necessitates 
the transport of strains between laboratories [33]. The 
latter is increasingly complex and expensive, par- 
ticularly between countries. 
Clearly, these problems could be overcome if 
agreed standardized methods could be adopted that 
allowed a laboratory to allocate an isolate to a ‘type’ and 
to then transmit this information, rather than the 
isolate, to the other laboratories involved with the 
investigations. Consequently, a strategy to develop a 
standardized approach to, and method for, typing of L. 
pneurnophila sg 1 within Europe was proposed and 
agreed by members of the EWGLI (Figure 1) [34]. 
The aims of the study were to (1) create a reference 
collection of representative European clinical isolates, 
and (2) identify valid and transportable genotypic 
(DNA-based) typing methods among those currently 
employed by participating laboratories. The methods 
were evaluated for their ability to identie epidemio- 
logically related isolates and to discriminate between 
unrelated strains of L. pneurnophila sg 1. From the data 
obtained, one (or more) method(s) would then be 
chosen for standardization as the agreed EWGLI 
molecular typing method in investigations of travel- 
associated legionellosis. 
MATERIALS AND METHODS 
Participants 
Participants from 12 institutions, representing 11 
European countries, took part in the study. Each of 
these laboratories acts as a local, or national, reference 
laboratory for legionella infections. The study was 
coordinated at the Respiratory and Systemic Infection 
Laboratory, PHLS Central Public Health Laboratory, 
London. 
Bacterial strains 
A collection of isolates, intended to be representative of 
European clinical isolates of L. pneumophila sg 1, was 
obtained from 10 of the participating laboratories. Each 
one provided their 10 most recent (i.e. consecutive) 
‘endemic’ clinical isolates that conformed to the 
following criteria: (1) that they were obtained from 
patients resident within that country who had not 
traveled to another country during the 2 weeks 
before onset of symptoms; and (2) that they were not 
epidemiologically related (temporally or geographi- 
cally) to any other isolate included in the panel. Not all 
laboratories were able to provide 10 strains, and one 
laboratory supplied 11, so 79 isolates were obtained. 
These ‘unrelated’ isolates comprised panel 1 (Table 1). 
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Table 1 Panel of 114 isolates of Legionella pneumophilu sg 1 from 10 European countries, showing epidemiologically 
‘unrelated’ and  ‘related’ isolates’ 
Panel 1 (n=79) ‘unrelated isolates’ Panel 2 (n=35) ‘related isolates’ 
EUL Sender Study code Country EUL Sender Study code Country Related 
no. designation no. of origin no. designation no. of origin to: 
1 
2 
3 
4 
6 
7 
8 
13 
14 
16 
17 
18 
19 
20 
25 
26 
27 
28 
29 
30 
31 
32 
33 
36 
37 
38 
39 
40 
41 
42 
43 
48 
49 
50 
51 
52 
53 
54 
55 
60 
63 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
IBS-2 
IBS-25 
IBS-26 
I B S - 3 0 8 
IBS-319 
IBS-320 
IBS-323 
83/41 091 
84/11316 
84/51978 
93/8188 
9406760 
94/51727 
95/9654 
L3 
L12 
L13 
L23 
L27 
L48 
L5 1 
L52 
L215 
1 
3 
4 
5 
6 
7 
8 
006/96 
16/96 
60/96 
16140/95 
13195/95 
6332/95 
1691/94 
2879/94 
001/92 
007/93 
013/86 
16/95 
LC3598 
LC3720 
LC3759 
LC3868 
LC3771 
LC3832a 
LC3290 
LC3196 
? 
L 
58 
85 
80 
75 
53 
31 
10 
12 
36 
48 
27 
9 
67 
103 
51 
7 
28 
100 
66 
20 
1 
70 
74 
23 
96 
71 
29 
26 
76 
32 
17 
62 
41 
68 
25 
72 
73 
56 
59 
18 
69 
4 
49 
83 
78 
99 
44 
45 
47 
39 
6 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Scotland 
Scotland 
Scotland 
Scotland 
Scotland 
Scotland 
Scotland 
France 
France 
France 
France 
France 
France 
France 
France 
France 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Spain 
Spain 
Spain 
Spain 
Spain 
Spain 
Spain 
Spain 
Greece 
Greece 
Greece 
Greece 
England and Wales 
England and Wales 
England and Wales 
England and Wales 
England and Wales 
England and Wales 
England and Wales 
England and Wales 
9 
10 
11 
12 
21 
22 
23 
24 
34 
35 
44 
45 
46 
47 
56 
57 
58 
59 
61 
62 
64 
76 
77 
78 
79 
94 
95 
96 
106 
107 
108 
109 
113 
114 
121 
IBS-134 
IBS-159 
IBS- 199 
IBS-200 
G-10 
94/51422 
94/51579 
94/51812 
L312 
L214 
9 
10 
11 
12 
17/96 
3144/95 
2880/94 
9706/93 
001/89 
002/89 
002/86 
LC3869 
LC3870 
LC3832b 
LC3832c 
L454 
L469 
L810 
LD92/94 
LD93/94 
LD319/92 
LD301/92 
11 
35 
46 
61 
33 
3 
63 
79 
86 
19 
84 
95 
81 
24 
2 
88 
89 
34 
5 
52 
54 
82 
77 
37 
42 
87 
55 
8 
38 
13 
111 
105 
Un4-Hannover 2 116 
Un5-Hannover 7 108 
R4-Augsburg 1 43 
Switzerland 
Switzerland 
Switzerland 
Switzerland 
Scotland 
Scotland 
Scotland 
Scotland 
France 
France 
Italy 
Italy 
Italy 
Italy 
Spain 
Spain 
Spain 
Spain 
Greece 
Greece 
Greece 
England and Wales 
England and Wales 
England and Wales 
England and Wales 
Denmark 
Denmark 
Denmark 
Sweden 
Sweden 
Sweden 
Sweden 
Germany 
Germany 
Germany 
EUL 3 
EUL 3 
EUL 8 
EUL 8 
EUL 16 
EUL 19 
EUL 19 
EUL 19 
EUL 33 
EUL 33 
EUL 37 
EUL 38 
EUL 38 
EUL 40 
EUL 48 
EUL 54 
EUL 55 
EUL 51 
EUL 60 
EUL 60 
EUL 63 
EUL 71 
EUL 71 
EUL 73 
EUL 73 
EUL 93 
EUL 93 
EUL 81 
EUL 97 
EUL 97 
EUL 104 
EUL 104 
EUL 112 
EUL 112 
EUL 120 
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Table 1 corttinued 
Panel 1 (n=79) ‘unrelated isolates’ Panel 2 (n=35) ‘related isolates’ 
EUL Sender Study code Country EUL Sender Study code Country Related 
no. designation no. of origin no. designation no. of origin to: 
81 
82 
83 
84 
85 
86 
87 
88 
91 
92 
93 
97 
98 
99 
100 
101 
102 
103 
104 
105 
110 
111 
112 
116 
117 
118 
119 
120 
R25 64 
R86 40 
R208 14 
R232 50 
R239 104 
R270 16 
R278 97 
R283 93 
R293 60 
L279 15 
L437 65 
LD91/94 109 
LD66/96 21 
LD35/95 101 
LD5/95 102 
LD 10/94 94 
LD162/93 106 
LD127/93 57 
LD320/92 90 
LD689/91 30 
Unl -S763 117 
Un2- Berlin1 115 
Un3-Hannoverl 98 
Un7-Wien60 112 
Un8-Wien 3 113 
R1-P 281 114 
R2-Ulm2 107 
R4-Augsburgl 110 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Denmark 
Sweden 
Sweden 
Sweden 
Sweden 
Sweden 
Sweden 
Sweden 
Sweden 
Sweden 
Germany 
Germany 
Germany 
Germany 
Germany 
Germany 
Germany 
Germany 
A second panel of epidemiologically ‘related’ 
isolates (panel 2)  was also assembled (Table 1). This 
panel comprised up to four isolates per laboratory 
(clinical or environmental), each of which was con- 
sidered to be epidemiologically related to one of the 
isolates in the ‘unrelated’ panel (panel 1). Details of the 
isolates that supported the view that they were ‘related’ 
were also requested from the submitting laboratories. 
Not all laboratories were able to provide four isolates, 
so 35 isolates were obtained, comprising panel 2 
(Table 1). These isolates, together with their ‘unrelated’ 
counterparts, comprised 22 sets (10 sets of two isolates, 
11 sets of three isolates and one set of four isolates) of 
‘epidemiologically related’ isolates (Table 1). 
On receipt at the coordinating laboratory, all 
isolates were given a unique EU Legionella (EUL) 
culture collection number. Their purity and identity 
were confirmed by standard methods [35] and they 
were archived by preservation in glycerol broth on glass 
beads at -80°C [35]. Replicates of each strain were 
prepared on BCYE agar (Oxoid, Basingstoke, UK) 
slopes, randomly allocated a study code number by one 
of the authors, and then distributed to each participant 
by courier. 
Study design 
Each center examined the coded isolates by their 
current genotypic typing method. They were asked to 
report the results to the coordinating center in 
whatever form was felt to be most appropriate (e.g. as 
‘type’ designations or as dendrogram outputs &om an 
appropriate software package). Where dendrograms 
were submitted, these were converted to ‘types’ at the 
coordinating laboratory by selecting a specified 
percentage sirmlarity at (or above) which strains were 
considered to be indistinguishable (i.e. they belonged 
to the same ‘type’). As some laboratories had only 
limited experience with the analysis of large numbers 
of isolates, the coordinating laboratory, where requested, 
undertook the data analysis on their behalf. In these 
instances, the originating laboratory provided results as 
gel or blot photographs or tagged image file format 
(TIFF) files. 
Evaluation of the genotypic methods was under- 
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taken broadly as outlined in the Consensus Guidelines 
of the European Study Group on Epidemiological 
Markers [36]. Typability ( T )  was calculated as the pro- 
portion of isolates assigned to a type by each method. 
Reproducibility (R) was not directly addressed in this 
study; rather, we chose to investigate the ability of 
each method to correctly identify epidemiologically 
related isolates as ‘related’ (i.e. the same type). This 
corresponds more closely to ‘epidemiologic con- 
cordance’ than to ‘reproducibility’ as defined in the 
Consensus Guidelines. Epidemiologic concordance 
( E )  was expressed as the number of ‘epidemiologically 
related’ sets of strains found to be indistinguishable by 
the typing system, divided by the total number of such 
sets in the study. The index of discriminatory power 
(0) of each method was determined by calculating 
Simpson’s index of diversity, as described by Hunter 
and Gaston [37]. 
An attempt was made to assess the convenience of 
each method. Factors such as the scale of investigations, 
financial and technical resources of the participating 
laboratories, rapidity and ease of use were considered. 
Monoclonal antibody subgrouping 
Monoclonal antibody (mAb) subgrouping was per- 
formed in two centers using one of two panels, 
designated ‘RSIL mAb Panel’ and ‘Dresden mAb 
Panel’. Both mAb panels are based on the International 
mAb subgrouping panel described by Joly et a1 [38]. 
The Dresden mAb Panel comprises seven mAbs (six 
Dresden mAbs plus mAb 3 from the International 
Standard Panel) and divides L. pneumophila sg 1 into 
nine phenons (‘Philadelphia’, ‘Benidorm’, ‘France/ 
Allentown’, ‘Knoxville’, ‘Bellingham’, ‘OLDA’, 
‘Oxford’, ‘Heysham’ and ‘Camperdown’), but cannot 
distinguish between the France and Allentown sub- 
groups [39]. The Dresden mAb Panel was used in an 
ELISA format standardized in the participants’ labora- 
tory [40]. 
The RSIL mAb Panel uses seven mAbs (all 
prepared in RSIL) and divides L. pneumophila sg 1 into 
eight phenons (‘Philadelphia/Allentown’, ‘Benidorm’, 
‘France’, ‘Knoxville’, ‘Bellingham’, ‘OLDA/Oxford’, 
‘Heysham’ and ‘Camperdown’), but cannot distinguish 
between the Philadelphia and Allentown, or the 
Oxford and OLDA, subgroups. The RSIL mAb Panel 
was used in an indirect immunofluorescence assay 
format [41]. 
Typing by restriction fragment length polymorphism (RFLP) 
analysis of genomic DNA 
Conventional restriction endonuclease analysis ( M A )  
The REA method used was modified from that of 
Gerner-Smidt et al [42]. Genomic DNA was dgested 
for 2 h at 37OC with the restriction endonucleases 
HaeIII or HhaI in appropriate buffers (New England 
BioLabs Inc., Beverly, MA, USA). The restriction 
fragments were separated using 0.7% agarose gels 
(ultraPURE; Life Technologies Inc., Rockville, MD, 
USA) in IXTBE (Tris-borate-EDTA) at 70 V for 
18 h. A mixture of the 1-kb ladder (Life Technologies) 
and bacteriophage lambda DNA (h) digested with 
Hind111 was used as molecular size marker. After 
electrophoresis, gels were stained with ethidium 
bromide (2 mg/L), visualized using UV trans- 
illumination and photographed. The results obtained 
for each enzyme were considered individually or in 
combination. 
Macrorestriction endonuclease analysis of genomic DNA 
resolved by pulsed- field gel electrophoresis (PFGE) 
Six different PFGE methods were used. Four of the 
methods employed the restriction endonuclease S$I, 
and two NutI. Except where indicated, the conditions 
used for the PFGE methods were based on those 
described by Luck et a1 [43,44], with the minor 
modifications detailed below. Following digestion of 
genomic DNA with $1 or NotI, electrophoresis was 
carried out using 1% agarose gels in 0.5 X TBE buffer 
(pH 8.3-8.5) using a CHEF DRII (Bio-Rad Labora- 
tories, Hercules, CA, USA), CHEF DR-111 apparatus 
(Bio-Rad) or Gene Navigator (Pharmacia Biotech, 
Uppsala, Sweden) and the conditions described below. 
Gels were stained with ethidium bromide, visualized 
using UV transillumination and photographed prior to 
analysis. 
PFGE I (Sfil) This method was modified from Poddar 
[45] and Maslow et a1 [46]. Each gel was run at 14”C, 
6 V/cm, for 30 h using a linear switch time ramp of 
1-35 s. Concatemers of the h genome were used as 
molecular size markers (PFGE Marker I; Boehringer 
Mannheim GmbH, Mannheim, Germany). 
PFGE 11 (Sfil) Each gel was run at 10°C, with a constant 
voltage of 150 V for 11 h, with constant pulse times (25 
-25 s), and for 11 h with a linear switch time ramp of 
35-60 s. Concatamers of the h genome were used as 
molecular size markers (PFGE Marker I, Boehringer). 
PFGE 111 (Sfil) Each gel was run at 14OC, with a constant 
voltage of 200 V for 24 h using a linear switch time 
ramp of 20-80 s. Concatemers of the h genome were 
used as molecular size markers (Lambda Ladder PFG 
Marker; New England Biolabs). 
PFGE IV (Sfil) Each gel was run at 14OC. 6 V/cm, for 
22 h using a linear switch time ramp of 1-50 s. 
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Sacckuromyces cerevisiae (02 1420,  Biometra, Goettingen, 
Germany) and h concatemers (021-022, Biometra) 
were used as molecular size markers. 
PFGE V(Notl)  Each gel was run at 14"C, with a constant 
voltage of 200 V for 24 h using a linear switch time 
ramp of 5-1 10 s.  Concatemers of the h genome (PFGE 
Marker I; Boehringer) and Sacckaromyces cerevisiae 
chromosomes (PFGE Marker 11; Boehringer) were 
used as molecular size markers. 
PFGE Vl (Notl) Each gel was run at 12OC, with a 
constant voltage of 200 V for 21 h using a linear switch 
time ramp of 60-90 s followed by 6 h using a linear 
switch time of 90-120 s. Saccharomyces cerevisiae (DNA 
Size Standard, Bio-Rad) was used as molecular size 
marker. 
RFLP with nocleic acid probes 
Two methods of RFLP analysis were used. The second 
method (RFLP 11) was performed in two separate 
centers as a measure of inter-laboratory reproduci- 
bility. 
RFLP I This was performed as described by Gaia et al 
[21]. Briefly, genomic DNA samples were con- 
comitantly digested with restriction endonucleases PstI 
and EcoRI (Boehringer) and the digested products 
separated by electrophoresis on 0.8% agarose (Molecular 
Biology Certified Agarose; Bio-Rad) gels in 1 XTBE 
for 16 h at 35-40 V. The 100-bp DNA ladder (Life 
Technologies) was used as molecular size marker. 
The DNA was then transferred onto a nylon mem- 
brane (Biodyne B transfer membrane; Pall Bio- 
Pharmaceuticals, New York, NYC, USA) and probed 
with digoxigenin-labeled plasmids. The probe was a 
genomic EcoRI DNA fragment of L. pneumo-pkila 
carried by pVG8, a pKNot plasmid [21]. Hybridization, 
washing and immunologic detection were performed 
according to the instructions of the manufacturer, using 
the DIG DNA Detection Kit (Boehringer). 
RFLP I1 This was performed as described by Saunders et 
a1 [24]. Briefly, genomic DNA samples were digested 
with the restriction endonuclease NciI (Boehringer), 
and digested products separated by electrophoresis on 
1 .O% agarose (ultraPURE; Life Technologies) gels in 
1 XTBE for 16 h at 28 V. A mixture of h DNA 
digested with EcoRI and PstI was used as molecular size 
markers. DNA was transferred to a nylon membrane 
(Hybond-N, Amersham International plc, Little 
Chalfont, England, UK or MAGNA, MSI, 
Westborough, MA, USA) and probed with two biotin- 
labeled lambda bacteriophages (hNS20 and hNS21). 
The two bacterio-phages were selected at random from 
a library of L. pneumopkilu EcoRI fragments in vector 
hgtWES.hB. Hybridization, washing and immunologic 
detection were performed as described previously [24]. 
Ribotyping 
Two methods of ribotyping were used. 
Ribotyping I This method was performed as described by 
Bangsborg et al [20]. Genomic DNA was digested with 
either HindIII or NciI (Boehringer). Molecular Weight 
Marker I1 (Boehringer), h digested with HindIII, was 
used as molecular size marker. Digested products were 
separated by electrophoresis on 0.7% agarose (SeaKem 
GTG, FMC Bioproducts, Rockland, ME, USA) gels 
for 18 h at 50 V in 1 XTAE buffer (40 mM Tris acetate, 
1 mM EDTA (PH 8.0)) and transferred onto a nylon 
membrane (Zetaprobe, Bio-Rad). The probe was 
digoxigenin-labeled cDNA derived from 16s and 23s 
Esckerickia coli rRNA. Hybridization, washing and 
immunologic detection were performed according to 
the instructions of the manufacturer, using the DIG 
DNA Detection Kit (Boehringer). Data from both 
restriction enzymes were combined for analysis. 
Ribotyping I1 This method was performed as described 
by Gaia et al [21]. Briefly, DNA samples were 
concomitantly digested with restriction endonucleases 
PstI and EcoRI (Boehringer), the digested products 
were separated by electrophoresis on 0.8% agarose 
(Molecular Biology Certified Agarose; Bio-Rad) gels 
in 1 XTBE for 16 h at 35-40 V, and the DNA was 
transferred to a nylon membrane (Biodyne B transfer 
membrane; Pall AG). The 100-bp DNA ladder (Life 
Technologies) was used as molecular size marker. The 
plasmid pKK3535 (a pBR322-derived plasmid carrying 
the rrnB rRNA operon of E. coli [47]) was used as a 
probe. The plasmid was labeled with digoxigenin (DIG 
DNA Labelling Kit; Boehringer). Hybridization, 
washing and immunologic detection were performed 
according to the instructions of the manufacturer, using 
the DIG DNA Detection Kit (Boehringer). 
Polymerase chain reaction (PCRI-based methods 
Two methods of PCR-mediated DNA fingerprinting 
were used. 
A P- PCR 
This method was as described by van Belkum et al [48], 
using the arbitrary primer BG2 (5'-TACATTCGA- 
GGACCCCTAAGTG-3'). The 1-kb DNA ladder 
and High DNA Mass Ladder (Life Technologies) were 
used as molecular size markers. 
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A P/rep- PCR 
This method was as described by van Belkum et al[48], 
using the primer BG2 (as above) together with the 
repeat sequence primer ERIC2 (5’-AAGTAAGTGA- 
CTGGGGTGAGCG-3’). DNA Molecular Weight 
Marker VI and Marker VIII (Boehringer) were used as 
molecular size markers. 
Amplified fragment length polymorphism analysis 
Amplified fragment length polymorphism (AFLP) 
analysis was carried out essentially as described by 
Valsangiacomo et a1 [49], with minor modifications. 
Restriction-ligation reactions were performed at 37°C 
for 3 h in a total volume of 20 pL. Each mix comprised 
approximately 1.5 pg of genomic DNA, 0.2 pg of each 
adapter-oligonucleotide (AFLP-LG1, 5 ’-CTCGTA- 
GACTGCGTACATGCA-3’; AFLP-LG2, 5’-TGT- 
ACGCAGTCTAC-3’), 20 U ofPstI (Boehringer), 1 U 
of T4 DNA ligase (Boehringer), and 1 X ligation buffer 
( X  10 ligation buffer is 660 mM Tris pH 7.5, SO mM 
magnesium chloride, 10 mM dithiothreitol, 10 mM 
ATP) (Boehringer). Prior to the PCR, tagged DNA 
fragments were precipitated and resuspended in TE 
buffer as previously described [49]. PCR was per- 
formed in a reaction mixture of 50 pL comprising 
approximately 1 ng of template, 400 nM selective 
primer (AFLP-PstI-G: 5‘-GACTGCGTACATGCA- 
GG-3’), 1 U of Taq polymerase (Boehringer), and 
1XPCR buffer (X10 PCR buffer is 100 mM Tris- 
HC1, 500 mM KC1, 15 mM MgC12 (pH 8.3)). 
Amplified products were separated by electrophoresis 
on 0.8% agarose (Molecular Biology Certified Agarose; 
Bio-Rad) gels in 1 X TBE for 16 h at 35-40 V. The 
100-bp ladder (Life Technologies) was used as mole- 
cular size marker. 
Data analysis 
Analyses of all patterns resulting from electrophoresis 
(gels or Southern blots) were performed either visually 
(directly from the gel photographs or developed 
Southern blots) or from scanned images using one of the 
following software packages: GelCompar (Applied 
Maths, Kortrijk, Belgium), Molecular Analyst (Bio- 
Rad), or Taxotron (Institut Pasteur, Paris, France). A 
wide range of percentage similarity values was assessed 
for each method, but only data for those considered 
‘optimal’ are presented here. In order to define the 
optimal results, visual examination of the data was done 
to ensure as far as possible that the percentage similarity 
thresholds (at or above which patterns were considered 
as belonging to the same type) were consistent with their 
intra- and inter-gel appearance. This was undertaken 
before the code was broken. Each D was then calculated 
using the optimal results for panel 1 ( ~ ~ 7 9 )  strains. 
RESULTS 
Typability 
All isolates included in this study were typable by all of 
the methods used (T= 1) [36]. 
Epidemiologic concordance 
It became apparent during the course of the study that 
some of the 22 sets of 2 3  isolates submitted as 
‘epidenuologically related’ could be clearly distin- 
guished by both mAb subgrouping and by the majority 
of the genotypic typing methods. Participants and 
the coordinating center therefore re-examined the 
epidemiologic ‘evidence of relatedness’ for all isolates. 
As a consequence of this review, the 22 sets were 
subdivided into three groups (Table 2). 
Subdivision I contained four sets of isolates for 
which compelling evidence of epidemiologic related- 
ness was available (e.g. multiple isolates from a single 
patient). 
Subdivision I1 contained 13 sets for which the 
evidence was consistent with the supposition of 
epidemiologic relatedness, and this view was supported 
by the mAb subgrouping data and a substantial number 
of genotypic methods. 
Subdivision I11 contained five sets where either (1) 
there were no epidemiologic data available, (2) the 
isolates were not recovered from the suspected source 
at the same time, or (3) the epidemiologic link between 
two patient isolates and an environmental isolate was 
not firmly established. 
Using these revised definitions, the E of each 
method was scored for subdivision I (termed ‘epidemio- 
logically related) and subdivision I1 (termed ‘probably 
epidemiologically related’) sets only. Subdivision 111 
(‘probably not related) was excluded from further 
analysis. 
These results, with an estimate of the analysis time 
of the methods from harvesting bacterial growth on 
culture plates, are shown in Table 3. 
Monoclonal subgrouping 
Two different panels of monoclonal antibodies were 
used, the RSIL mAb Panel and the Dresden mAb 
Panel. The two panels divided the 114 study isolates 
into six and seven phenons respectively. The RSIL 
mAb phenons comprised Bellingham, Benidorm, 
France, Knoxville, Oxford/OLDA, and Philadelphia/ 
Allentown, while the Dresden phenons comprised 
Bellingham, Benidorm, France/Allentown, Knoxville, 
OLDA, Oxford, and Philadelphia. The monoclonal 
subgroups Heysham and Camperdown were not 
encountered in the study strains using either panel. The 
different patterns of reactivity of the mAbs in each 
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Table 2 Epidemiologically related strains: results of monoclonal antibody subgrouping and evidence of relatedness. 
Subdivision I11 was excluded fiom further analysis in this study 
mAb subgroup 
EUL Sender Study 
no. designation code no. Evidence of relatedness RSIL Dresden 
Subdivision 1 (‘related’) 
120 R4-Augsburgl 110 
121 R4-Augsburgl 43 Duplicate of above strain 
73 LC3832a 47 Patient 
78 LC3832b 
79 LC3832c 
71 LC3868 44 Patient (sputum isolate-direct culture) 
76 LC3869 82 Same specimen but isolated via amoebae 
77 LC3870 77 Same patient but from feces 
48 006/96 62 Patient 
56 17/96 2 Same patient (15 days later) 
each is a single colony 
42 37 I picked from the isolation plate 
Subdivision I1 (‘probably related’) 
3 
9 
10 
8 
11 
12 
19 
22 
23 
24 
33 
34 
35 
37 
44 
45 
38 
46 
40 
47 
51 
59 
54 
57 
55 
58 
81 
96 
93 
94 
95 
97 
106 
107 
IBS-26 
IBS-134 
IBS-159 
IBS-323 
IBS-199 
IBS-200 
94/51727 
94/51422 
94/51579 
94/51812 
L215 
L212 
L214 
2 
9 
10 
3 
11 
5 
12 
16140/95 
9706193 
2691/94 
3144/95 
2879194 
2880/94 
R25 
L810 
L437 
L454 
L469 
LD91/94 
LD92/94 
LD93/94 
80 
11 
35 
10 
46 
61 
67 
3 
63 
79 
74 
86 
19 
96 
84 
95 
71 
81 
26 
24 
25 
34 
56 
88 
59 
89 
64 
8 
65 
87 
55 
109 
38 
13 
Patient 
Water (spa) 
Water (spa) 
Patient 
Water (rest home) 
Water (rest home) 
Patient 1 
Patient 2 (same outbreak) 
Patient 3 (same outbreak) 
Related environmental 
Patient 
Related environmental 
Related environmental 
Patient 1 
Related environmental 
Related patient 
Patient 
Related environmental 
Patient 
Related environmental 
Patient (hotel associated) 
Shower water of hotel 
Patient (hotel associated) 
Shower water of hotel 
Patient (nosocomial) 
Shower in same hospital 
Environmental isolate 
Patient (community acquired) 
Patient (nosocomial) 
Related patient 
Related environmental 
Patient (community acquired) 
Same patient 
Related environmental 
Benidorm 
Benidorm 
Phdadelphia/ Allentown 
Philadelphia/Allentown 
Philadelphia/Allentown 
Philadelphia/ Allentown 
Philadelphia/Allentown 
Philadelphia/ AUentown 
Bellingham 
Bellingham 
Philadelphia/AUentown 
Philadelphia/AUentown 
Philadelphia/AUentown 
Philadelphia/Allentown 
Philadelphia/Allentown 
Philadelphia/Allentown 
Knoxville 
Knoxville 
Knomlle 
K n o d e  
France 
France 
France 
Philadelphia/AUentown 
Philadelphia/Allentown 
Philadelphia/Allentown 
Oxford/OLDA 
Oxford/OLDA 
Philadelphia/AUentown 
Philadelphia/Allentown 
Bellingham 
Bellingham 
France 
France 
Oxford/OLDA 
Oxford/OLDA 
Bellingham 
Bellingham 
Oxford/OLDA 
Oxford/OLDA 
Oxford/OLDA 
Knoxville 
Knoxville 
Knoxville 
Benidorm 
Benidorm 
Philadelphia 
Philadelphia 
Philadelphia 
France/Allentown 
France/Allentown 
France/AUentown 
Bellingham 
Bellingham 
Philadelphia 
Philadelpha 
Philadelphia 
France/Allentown 
France/AUentown 
France/Allentown 
Knoxville 
Knoxville 
Knoxville 
Knoxville 
France/AUentown 
France/Allentown 
France/Allentown 
Philadelphia 
Philadelphia 
Philadelphia 
OLDA 
OLDA 
Philadelphia 
Philadelphia 
Bellingham 
Bellingham 
France/AUentown 
France/Allentown 
OLDA 
OLDA 
Bellingham 
Bellingham 
Oxford 
Oxford 
Oxford 
Knoxville 
Knoxville 
Knoxville 
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Table 2 continued 
mAb subgroup 
EUL Sender Study 
no. desienation code no. Evidence of relatedness RSIL Dresden 
Subdivision III (‘probably not related’) 
63 007/93 69 Patient (?hotel related) 
64 002/86 54 Same hotel but 7 years earlier 
112 Un3-Hannoverl 98 Origin unclear 
113 UnCHannover2 116 Origin unclear 
114 UnS-Hannover7 108 Origin unclear 
16 8WS1978 48 Patient 
31 G-10 33 ?Related environmental 
60 001/92 18 Patient (?nosocomal) 
61 001/89 5 Same hospital but 3 years earlier 
62 002’89 53 Same hospital but 3 years earlier 
104 LD320/92 90 Patient (community acquired) 
108 LD319/92 111 Patient (isolated same area/time) 
109 LD301/92 105 Related environmental 
panel meant that results were not always directly 
comparable. However, when this is taken into account 
(for example, it is accepted that the designation of an 
isolate as a Philadelphia/Allentown using the RSIL 
mAb Panel is consistent with it being designated as 
either a Philadelphia or an AllentowdFrance using the 
Dresden Panel), there was 100% agreement between 
the results obtained in both centers. 
The index of discrimination was calculated to be 
0.800 for the RSIL mAb Panel, 0.838 for the Dresden 
mAb Panel and 0.845 for the combined results (which 
equates to the original ‘International Panel’ of Joly et 
al [38]). Isolates within each of the epidemiologically 
related sets in subdivisions I and I1 were found to be of 
the same monoclonal subgroup, i.e. E=l.  
Genotypic methods 
Inter-laboratory reproducibility 
Although a number of genotypic methods were used in 
more than one center, the experimental conditions 
used usually differed. Consequently, only data for 
RFLP method 11, obtained in two centers, could be 
considered evaluable for inter-laboratory estimates of 
reproducibility. One center was only able to examine 
79 of the 115 strains, but data for these showed 100% 
agreement with the data from the second center (data 
not shown). 
Discriminatory power 
Figure 2 shows examples of the results obtained with a 
selection of the genotypic methods used. The total 
number of ‘types’ identified by each typing method 
ranged from 11 (using ribotyping I1 with 100% 
Knoxville 
Knoxville 
Oxford/OLDA 
Oxford/OLDA 
Oxford/OLDA 
Benidorm 
Philadelphia/Allentown 
Philadelphia/Allentown 
Knoxville 
Oxford/OLDA 
Oxford/OLDA 
Philadelphia/Allentown 
Knoxville 
Knoxville 
OLDA 
OLDA 
OLDA 
Benidorm 
Philadelphia 
Philadelphia 
Knoxville 
OLDA 
Oxford 
France/AUentown 
Oxfo/OLDA OLDA 
similarity threshold) to 65 (using PFGE I1 with a 100% 
similarity threshold). The index of discrimination was 
calculated for each method as described above and 
ranged from 0.840 (using ribotyping I1 with 100% 
similarity threshold) to 0.990 (using PFGE I1 with 
100% similarity threshold) (Table 3). 
In general, the highly discriminatory AP/rep-PCR 
and PFGE methods showed a low value of E, while for 
the least discriminatory methods, such as ribotyping I1 
and RFLP I, E was high (0.94 and 1.00 respectively). 
DISCUSSION 
Our purpose was to identify the best genotypic 
method(s) for the epidemiologic typing of L. pneumo- 
phila sg 1 in current use in European laboratories. In 
attempting this, it was understood that, at least in the 
context of this study, the evaluation was not only of the 
genotypic methods used (eg. whether PFGE or REA 
is the best method), but was also concerned with 
aspects of data analysis, presentation and turnaround 
time: in fact, all the components which lead from 
receipt of an isolate to allocation to a particular ‘type’. 
Although not strictly part of the evaluation of 
genotypic methods, two laboratories undertook mAb 
subgrouping to confirm the utility of this method and 
to compare their mAb panels. Subgrouping using mAbs 
was standardized for L. pneumophila sg 1 by Joly et a1 
[38]. While this method was not highly discriminatory 
(only 10 phenons, of which five account for most 
clinical cases [50]), it has repeatedly been shown to be 
rapid, robust and reproducible, at least in the context of 
timely outbreak investigations. Consequently, mAb 
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M 2 62 M M 37 M 42 M 47 M 43 110 M M 44 77 M 82 
(B) 
(C) 
(D) 
M 31 42 M 47 M 4 3  110 M 44 62 
M 37 M 42 47 M 43 M 3 1 0  M M M n M 82 
(G) 
M 2 62 M M 37 M 4 2 4 7  M 43 110 M M 44 M 77 82 M 
Figure 2 Examples of the patterns obtained with a selection of the genotypic methods with the four sets of 
'epidemiologically related' strains of L. pneumophila sg 1 (subdivision I). The four epidemiologically related sets comprise 
study code numbers 2 and 62, 37, 42 and 47, 43 and 110, and 44, 77 and 82. Where results from different gels or blots are 
combined, markers from each gel/blot are included. See text for details of methods. (A) Electrophoretic results of restriction 
endonuclease analysis (REA) with HaeIII. (B) Electrophoretic results following PFGE 111 with SjI. (C) Electrophoretic 
results following PFGE VI with NotI. (D) Southern blots following NciI digests with RFLP I. (E) Southern blots following 
Hind111 digestion with ribotyping I. (F) PCR DNA fingerprinting using an arbitrary (BG2) and repeat sequence primer 
(ERIC2). (G) Electrophoretic results of AFLP analysis using PstI with selective primer AFLP-Pst I-G. 
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subgrouping is an ideal screening tool with which to 
examine large numbers of isolates to determine which 
should be further investigated by a molecular typing 
method (Figure 1). Unfortunately, several of the 
monoclonal antibody-secreting cell lines included in 
the International Panel are no longer available; 
however, it is clear that, by combining results of the 
RSIL and Dresden mAb Panels, all isolates could be 
allocated to one of the International Panel subgroups. 
Members of the EWGLI are now working to reinstate 
ths revised ‘International Panel’ and to make it widely 
available to reference laboratories. 
Most of the participants have considerable exper- 
ience of typing L. pneumophila and have established 
that, within their laboratory, their chosen method is 
both reproducible and discriminatory. However, with 
few exceptions, the methods employed have been 
used to ‘fingerprint’ rather than to type’ the isolates. 
Although adequate for local purposes, as detailed in the 
introduction, this approach is of little use in the context 
of European travel-associated legionellosis. The strategy 
used for this study was therefore to send out a coded 
set of representative isolates to all laboratories. 
Participants then examined these strains using their 
current methodology, but submitted results as ‘type’ 
designations (or data which could be translated into a 
‘type’ by the coordinating laboratory). From these data, 
the most discriminatory method, taking account of 
epidemiologic concordance, was then selected with the 
intention that all other participants would then seek to 
implement this methodology, in its entirety, in their 
laboratories. 
REA has been applied, using a variety of restriction 
enzymes, by many workers to the typing of L. 
pneurnophila isolates and has been found to be a highly 
discriminatory method [13,14,51-551. The results 
presented here confirm this, with excellent dis- 
crimination being obtained, particularly where the 
results for both enzymes were combined. Furthermore, 
these data show that the inter-gel intra-laboratory 
reproducibility of REA can be very good. Although it 
might appear from these data that REA would be an 
ideal method to adopt for standardization, it was 
concluded by the authors that, given the degree of skill 
and experience needed for the reproducible visual 
interpretation of results, it was unlikely that the method 
would be successful if used widely. To our knowledge, 
computer analysis of REA patterns, which would, in 
theory, improve inter-laboratory comparison of multiple 
data sets, has not been attempted. Given the number 
and proximity of the bands, such an approach may well 
be impractical. 
Of the many molecular typing methods applied to 
L. pneumophila, PFGE is probably the most widely used 
and is generally considered to be highly discriminatory 
[16,18,19,43]. Again, the results of this study confirm 
this view. Of the two restriction enzymes used in this 
study, SjI was generally more discriminatory than NotI, 
but the latter gave relatively simple profiles which were 
easier to interpret visually. Data obtained by PFGE 
were difficult to interpret by computer analysis, and this 
was reflected in the low E values obtained. Studies have 
shown that, within a laboratory, PFGE using SjI can 
be used to ‘type’, rather than ‘fingerprint’, L. pneumo- 
philu sg 1 with a reasonable degree of reproducibility 
[56]. It remains to be seen if careful standardization of 
the methodology and data analysis is sufficient to obtain 
good inter-laboratory reproducibility. 
As anticipated from earlier work, RFLP and 
ribotyping gave high E values, but were not highly 
discriminatory with individual enzymes [20,21,28]. 
RFLP I1 has been the established typing method in the 
UK for about 10 years and, in combination with mAb 
subgrouping, has proved to be very usell 1571. The 
potential of this method to accurately allocate strains to 
a designated ‘type’ when examined in more than one 
laboratory was demonstrated, as it was used in two 
centers. For those isolates examined, completely con- 
cordant results were obtained (data not shown). How- 
ever, both RFLP and ribotyping involve Southern 
blotting and are therefore technically complicated, 
time-consuming and relatively expensive to perform. 
Using more than one enzyme can improve the 
discrimination, but this also lengthens the analysis time. 
Two centers undertook DNA fingerprinting using 
AP-PCR or AP/rep-PCR. The discrimination was 
found to be better with AP/rep-PCR (D=0.979) using 
computer-assisted analysis of the results than for AP- 
PCR using visual interpretation, but both methods 
gave very low E values. This is perhaps not surprising. 
Other workers have used AP-PCR (RAPD) or rep- 
PCR, but only in the context of ‘DNA fingerprinting’ 
[48,58]. Sources of variation in such methodologies 
have been described in detail elsewhere [59]. Recent 
work on Acinetobacfer spp. reports that use of automated 
high-resolution laser fluorescence analysis improved 
both intra- and inter-laboratory reproducibility [60], 
but this approach requires specialist equipment that may 
not be readily accessible or affordable. 
The AFLP method used here was first reported by 
Valsangiacomo et al in 1995 [49]. These authors tested 
this novel method for the molecular typing of L. 
pnetrmophila. This AFLP method consists of a simple 
restriction-ligation reaction and a subsequent PCR 
amplification. In a single-step reaction, the genomic 
DNA is digested and the restriction fragments ligated 
to specially constructed adapters. PCR amplification 
of such tagged restriction fragments with primers 
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complementary to the adapters allows the detection of 
RFLPs upon resolution on agarose gels. The original 
paper reported the method to be fast, efficient and 
reproducible. In this study, the results obtained were 
very good. It was one of only two methods to give an 
E value of 1.00. The D value (0.891) approximates to 
that described by Hunter and Gaston [37] as desirable, 
but is lower than the value of 0.95, values above which 
are generally considered to be ideal [36]. However, if it 
is assumed that AFLP would be undertaken after mAb 
subgrouping, the effective D in this study was 0.963 
using the more discriminatory Dresden mAb Panel. 
Furthermore, the method is rapid, the equipment and 
reagents required are widely available or easily obtained, 
and the data appear to be amenable to computer- 
assisted analysis. 
The difficulty of selecting the optimum percentage 
similarity between two isolates at, or above, which they 
are considered to be indistinguishable is illustrated well 
by data for PFGE I1 using S$I. Where stringent criteria 
were adopted, requiring isolates allocated to the same 
type to be 100% similar, the D was excellent (0.990), 
but E was very low (0.24). With an acceptance that any 
isolates with 290% similarity were indistinguishable 
(which broadly corresponds to a two-band difference), 
the D fell to 0.983, and E rose to 0.59. Using a 
similarity threshold of SO%, the D fell to 0.968, but E 
improved only a little at 0.65 (data not shown). These 
data illustrate well the usual trade-off between the 
discriminatory power of a technique and its repro- 
ducibility. The low values of E obtained, particularly 
with PFGE, can be explained by the difficulty in 
interpretation of banding patterns (both visually and 
using analysis sofmare), and may not be due to the 
method itself. It may be that alternative strategies of 
data analysis (particularly in inter-gel comparisons) 
might have given even better results, and this warrants 
further study. 
There is now a wide range of genotypic methods 
that allow the discrimination of micro-organisms for 
epidemiologic typing. The high level of discrimination 
provided by PFGE has led to it being the method of 
choice for many microorganisms [61,62]. The data 
presented here give support to this view in relation to 
typing L. pneumophila. However, the increased speed 
offered by PCR-based techniques cannot be ignored, 
although to date these have mainly remained at the level 
of DNA fingerprinting. The development of AFLP 
appears to offer a technique that combines discrimina- 
tion, offered by restriction endonuclease-based methods, 
with speed, offered by PCR-based methods, but allows 
the level of discrimination to be adjusted (by the choice 
of restriction endonuclease and selective primers) to 
ensure good reproducibility. 
For these reasons, the EWGLI has decided to adopt 
two methods for rigorous standardization [63]; PFGE 
using $1 and AFLP. Standardized protocols have now 
been prepared, and studies are underway to determine 
both the intra- and inter-laboratory reproducibility of 
these methods. 
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